Evaluation of ARK5 and SIRT3 expression in renal cell carcinoma and their clinical significance.

Autor: Elkady N; Pathology Department, Faculty of Medicine, Menoufia University, Shibin El Kom, Menoufia, 32511, Egypt., Aldesoky AI; Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Menoufia University, Shibin El Kom, Menoufia, Egypt., Dawoud MM; Pathology Department, Faculty of Medicine, Menoufia University, Shibin El Kom, Menoufia, 32511, Egypt. marwa.dawood@med.menofia.edu.eg.

Publikováno v: Diagnostic pathology [Diagn Pathol] 2023 Nov 23; Vol. 18 (1), pp. 125. Date of Electronic Publication: 2023 Nov 23.

Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific Signatures.

Autor: Gouda MA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA.; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Menoufia University, Shebin Al-Kom, Egypt., Duose DY; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Lapin M; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Zalles S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Huang HJ; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA., Xi Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, USA., Zheng X; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, USA., Aldesoky AI; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Menoufia University, Shebin Al-Kom, Egypt., Alhanafy AM; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Menoufia University, Shebin Al-Kom, Egypt., Shehata MA; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Menoufia University, Shebin Al-Kom, Egypt., Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, USA., Kopetz S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Luthra R; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Janku F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA.

Publikováno v: The oncologist [Oncologist] 2023 Apr 06; Vol. 28 (4), pp. 368-372.